We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$447M
AUM Growth
+$34.4M
Cap. Flow
+$25.4M
Cap. Flow %
5.68%
Top 10 Hldgs %
63.53%
Holding
36
New
5
Increased
15
Reduced
9
Closed
7

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$23.6M
2
BAX icon
Baxter International
BAX
+$13.4M
3
GEHC icon
GE HealthCare
GEHC
+$12.1M
4
AMED
Amedisys
AMED
+$5.83M
5
GILD icon
Gilead Sciences
GILD
+$4.67M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$8.12M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$7.29M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.52M
4
QGEN icon
Qiagen
QGEN
+$6.06M
5
MRK icon
Merck
MRK
+$5.97M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$167B
$46.3M 10.37%
601,367
+58,594
+11% +$4.67M
CAH icon
2
Cardinal Health
CAH
$53.5B
$36.4M 8.14%
384,642
+7,941
+2% +$671K
BMY icon
3
Bristol-Myers Squibb
BMY
$124B
$32.5M 7.26%
507,576
+58,005
+13% +$3.89M
MDT icon
4
Medtronic
MDT
$106B
$30.5M 6.83%
346,508
+27,604
+9% +$2.38M
BIIB icon
5
Biogen
BIIB
$30.4B
$27.3M 6.1%
95,757
+7,921
+9% +$2.36M
INCY icon
6
Incyte
INCY
$23.4B
$24.7M 5.54%
397,532
-34,703
-8% -$2.32M
BDX icon
7
Becton Dickinson
BDX
$43.6B
$24.5M 5.49%
+92,923
New +$23.6M
ZBH icon
8
Zimmer Biomet
ZBH
$17.6B
$21.7M 4.85%
148,812
-27,291
-15% -$3.71M
BAX icon
9
Baxter International
BAX
$11.7B
$21.6M 4.83%
473,634
+306,634
+184% +$13.4M
EW icon
10
Edwards Lifesciences
EW
$49.4B
$18.4M 4.12%
195,291
+36,485
+23% +$3.17M
LH icon
11
Labcorp
LH
$23.2B
$17.6M 3.95%
85,093
-9,674
-10% -$1.88M
CNC icon
12
Centene
CNC
$32.8B
$16.5M 3.7%
244,949
+6,203
+3% +$414K
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$11.5B
$14.1M 3.15%
162,668
+6,318
+4% +$595K
ELV icon
14
Elevance Health
ELV
$80.9B
$13.9M 3.12%
31,351
-4,428
-12% -$2.04M
THC icon
15
Tenet Healthcare
THC
$16.8B
$13.1M 2.94%
161,457
-3,770
-2% -$268K
GEHC icon
16
GE HealthCare
GEHC
$28.7B
$12.3M 2.75%
+151,328
New +$12.1M
NUVA
17
DELISTED
NuVasive, Inc.
NUVA
$11.1M 2.48%
266,370
+32,614
+14% +$1.34M
BRKR icon
18
Bruker
BRKR
$8.86B
$8.3M 1.86%
112,242
-40,875
-27% -$3.12M
CTLT
19
DELISTED
CATALENT, INC.
CTLT
$7.81M 1.75%
180,088
+29,587
+20% +$1.3M
IONS icon
20
Ionis Pharmaceuticals
IONS
$8.99B
$6.58M 1.47%
160,401
+13,960
+10% +$536K
AMED
21
DELISTED
Amedisys
AMED
$6.49M 1.45%
+71,007
New +$5.83M
QGEN icon
22
Qiagen
QGEN
$8.49B
$5.74M 1.28%
120,264
-125,673
-51% -$6.06M
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$35.7B
$5.33M 1.19%
28,067
+678
+2% +$134K
ACAD icon
24
Acadia Pharmaceuticals
ACAD
$4.38B
$4.81M 1.08%
200,696
-32,022
-14% -$712K
RARE icon
25
Ultragenyx Pharmaceutical
RARE
$2.88B
$4.64M 1.04%
100,605
-5,677
-5% -$263K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2023 Portfolio in Review

As of Q2 2023, Sector Gamma AS held 36 positions worth $447M, up 8.4% from $412M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Sector Gamma AS deployed $25.4M of net new capital in Q2 2023, opening 5 new positions and adding to 15 existing holdings. Its largest new stake was Becton Dickinson: 92,923 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Qiagen, an estimated $6.06M trimmed.

  • Sector Gamma AS's largest Q2 2023 buy was Becton Dickinson: 92,923 shares worth $24.5M.
  • Sector Gamma AS added most to Baxter International in Q2 2023, an estimated $13.4M increase.
  • Sector Gamma AS's biggest Q2 2023 reduction was Qiagen, cutting an estimated $6.06M.
  • Sector Gamma AS fully exited Boston Scientific in Q2 2023, selling an estimated $8.12M.
  • Sector Gamma AS's ten largest holdings make up 64% of its $447M portfolio in Q2 2023.
  • Sector Gamma AS opened 5 new positions and closed 7 in Q2 2023.
  • Sector Gamma AS's portfolio value rose 8.4% quarter-over-quarter to $447M.

Based on Sector Gamma AS's 13F filing for Q2 2023, filed 9 Aug 2023.